$0.565800
-0.01-2.28%
At Close: -
$0.570000
0.00420.74%
After Hours: 7:58 PM EDT
15 minutes delayed
Comments
Loading...
BioXcel Therapeutics (BTAI) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBioXcel Therapeutics (NASDAQ:BTAI) Stock Quotes, Forecast and News Summary
BioXcel Therapeutics Stock (NASDAQ: BTAI) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioXcel Therapeutics (BTAI) stock?
You can purchase shares of BioXcel Therapeutics (NASDAQ:BTAI) through any online brokerage.
Who are BioXcel Therapeutics (BTAI) competitors?
Other companies in BioXcel Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT), Geovax Labs (NASDAQ:GOVX) and Palatin Techs (AMEX:PTN).
What is the forecast, or price target, for BioXcel Therapeutics (BTAI) stock?
BioXcel Therapeutics has a consensus price target of $7.43.
What is the current price for BioXcel Therapeutics (BTAI)?
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $0.57 last updated September 24, 2024 at 7:58 PM EDT.
Does BioXcel Therapeutics (BTAI) pay a dividend?
There are no upcoming dividends for BioXcel Therapeutics.
When is BioXcel Therapeutics (NASDAQ:BTAI) reporting earnings?
BioXcel Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is BioXcel Therapeutics (BTAI) going to split?
There is no upcoming split for BioXcel Therapeutics.
What sector and industry does BioXcel Therapeutics (BTAI) operate in?
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.